Form 4 for RGNX REGENXBIO Inc.
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001562180-25-003822 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-05-14 | 2025-05-12 | RGNX | Mills Kenneth T. | Dir | M - OptEx | $3.76 | +20.6K | 495.7K | +4% | +$77.5K |
| DT | 2025-05-14 | 2025-05-12 | RGNX | Mills Kenneth T. | Dir | S - Sale+OE | $7.91 | -20.6K | 475.1K | -4% | -$163.0K |
| DT | 2025-05-14 | 2025-05-12 | RGNX | Mills Kenneth T. | Dir | M - OptEx | $0.00 | -20.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-12 | M | A | 20,602 | $3.76 | 495,705 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-12 | S | D | 20,602 | $7.91 | 475,103 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $7.66 to $8.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Stock Options (Right to Buy) | 2025-05-12 | M | D | 20,602 | $0.00 | 0 | D | $3.76 · — to 2025-05-19 | 20,602 Common Stock | (F3) The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. |